BioAegis Therapeutics
Phase 1BioAegis Therapeutics is focused on developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin (pGSN), a naturally occurring human protein that is at the core of a system to regulate the innate immune response.
Founded
2013
Focus
Biologics
About
BioAegis Therapeutics is focused on developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin (pGSN), a naturally occurring human protein that is at the core of a system to regulate the innate immune response.
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedJun 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2013
LocationBoston, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile